Health
OHDSI awarded $10 MM FDA contract to monitor safety/effectiveness of vaccines, biologics – EurekAlert
A team of observational health data researchers, coordinated by Columbia University, will support an FDA program to conduct safety and effectiveness surveillance…
NEW YORK, NY (Dec. 1, 2020)–Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
The lead research team, primarily comprised of OHDSI personnel from Columbia University, UCLA, and Northeastern University,…
-
General6 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General5 hours agoHow a fake expert crashed the World | The West Report
-
General4 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business4 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher